Featured news

Successful outcome in US CRISPR patent interference against SNIPR Biome

“In November 2021, US “Interference” proceedings resulted in cancellation of five US patents owned by SNIPR TECHNOLOGIES. It was concluded that the technology claimed in those patents was invented earlier by The Rockefeller University. The University have their own earlier patent filing focused on that technology, which is licenced exclusively to ELIGO.”


The presence or absence of a single bacterial gene can trigger or aggravate a variety of diseasesI


 This genetic causality is being demonstrated in a growing number of therapeutic areas 



Introducing our GEM (Gene Editing of the Microbiome) platform

A first-in-class proprietary platform to edit the microbiome gene repertoire in vivo

We are hiring!

Join Our Team

Our Partners & Investors